Having completed the British 10k on Sunday, my final week at the UKSCF started by discussing the run and how it had gone with my colleagues. However, before long I was back to work.
I began the week by responding to queries that had been sent into the charity by individuals enquiring about places on clinical trials. I had to advise them on the costs and benefits of different clinical trials, as well as guide them towards useful tools to research and understand the implications of taking part in a clinical trial. This exposed me to some of the people that the charity is trying to help by funding research, and it served me as motivation to imagine the situation that they must be in and the fact that we must be somewhat of a final hope.
Weeks 2 and 3:
My second week began much the same as my first finished – I continued to produce a database of contacts, which we could contact to help us with the opening of a Centre for Regenerative Medicine in Sport and Trauma. I extended the database from sports clubs, brands and bloggers to include sportsmen and women who had retired due to injury and startup companies to target for a corporate partnership. Having completed research for all of the charity groups that I had been assigned, I compiled a list of the top 10 male and female sports stars that I believed we should target using criteria such as sport played, injury history and current charity links.
My first day:
I arrived at the rather impressive Royal Institute of Great Britain ready to begin work at the UK Stem Cell Foundation. I entered the building where I met my supervisor, Hugh. He gave me a brief induction and tour of the building, including the theatre where so many major scientific discoveries have been announced.
With the welcome over, we began discussing my role at the charity in more detail and the plan of action for my first week: RESEARCH. I was to build a network of sportsmen and women, sports club, sports brands and sports bloggers to contact about becoming involved with raising public awareness of the UKSCF.